SCHEMBL7145273

SCHEMBL7145273

CC(C)(C)OC(=O)C12CNCC1CC(=O)C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14249653 0.82
SCHEMBL4671436 0.77
SCHEMBL4748100 0.75 CYP3A4 (0.31) MAPK1
SCHEMBL2670466 0.73 GAA (0.35)
SCHEMBL14699482 0.73
SCHEMBL21602004 0.67 SLC6A2 (0.38)
SCHEMBL15897448 0.66 MAPK1 (0.33) MAPK1
SCHEMBL10396311 0.65 ALDH1A1 (0.32)
SCHEMBL2318788 0.65 TSHR (0.32) MAPK1
SCHEMBL585092 0.64 CYP17A1 (0.36) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed